Zepbound® contains tirzepatide which was approved for weight loss in November 2023. This injectable medication is renowned for its dual function on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. As a GLP-1 medication, tirzepatide mimics the effects of GLP-1, a natural hormone crucial in regulating glucose and appetite. Its dual-action function helps with weight loss by slowing gastric emptying, promoting a sense of fullness, and balancing blood sugar levels.
Weight loss medications like Zepbound® require purposeful lifestyle changes, including regular exercise and a balanced diet. Using weight management medications without integrating these changes may only provide temporary effects, rather than long-term results.
Benefits of Zepbound® include:
-
Revolutionary dual mechanism: Zepbound® combines appetite regulation and metabolic enhancement, setting it apart from traditional weight loss approaches.
-
Rapid weight loss results: Potential to experience noticeable changes in your weight within weeks, making Zepbound® an effective solution for those seeking quick results.
-
Clinically supported: Backed by scientific research, rigorous studies, and clinical trials support tirzepatide's efficacy in weight loss, leading to a weight loss of up to 48 lbs in some individuals.1
Committed to tailored weight management solutions, we recognize Zepbound® as an excellent choice for many. However, we want to suggest alternative options for individuals seeking the most suitable treatment. Depending on availability and individual preferences, our physicians may recommend or prescribe other GLP-1 options:
-
Compounded tirzepatide: During the recent FDA shortages, compounded tirzepatide was prescribed as an alternative to branded Zepbound® when Zepbound® is on the FDA drug shortages list, compounded tirzepatide may be prescribed, when it is not on the FDA drug shortage list, it cannot be prescribed. While compounded tirzepatide is not FDA-approved, our preferred pharmacy provider adheres to all relevant federal and state regulations and FDA guidelines.*
-
Wegovy® (semaglutide): Administered through a convenient weekly injection, Wegovy® stands as a leading weight management medication designed to complement a balanced lifestyle.
-
Semaglutide: Due to shortages, compounded semaglutide may be prescribed as an alternative to branded Wegovy® as long as it remains on the FDA drug shortages list. Although compounded semaglutide is not FDA-approved, our preferred pharmacy provider complies with pertinent federal and state laws and FDA regulations.*
Other weight loss medications our doctors may prescribe include:
*Availability for compounded semaglutide and tirzepatide is limited to residents in the following states:
Compounded Semaglutide: AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, VA, WA, WV, Washington D.C., WY.
Compounded Tirzepatide: AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, VA, WA, WV, Washington D.C., WY.
Although compounded semaglutide and tirzepatide are not FDA-approved, our preferred pharmacy provider complies with all federal and state laws and FDA regulations.
